|
TAF1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.74650000001253E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.800130E-03 |
| Normal-vs-Stage2 |
1.221370E-01 |
| Normal-vs-Stage3 |
1.70595999999801E-05 |
| Normal-vs-Stage4 |
5.41579999735475E-08 |
| Stage1-vs-Stage2 |
9.297600E-01 |
| Stage1-vs-Stage3 |
4.606300E-02 |
| Stage1-vs-Stage4 |
1.060310E-03 |
| Stage2-vs-Stage3 |
2.387200E-01 |
| Stage2-vs-Stage4 |
5.851500E-02 |
| Stage3-vs-Stage4 |
2.763600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.24410000000597E-05 |
| Normal-vs-AfricanAmerican |
9.6379999536822E-09 |
| Normal-vs-Asian |
8.021600E-01 |
| Caucasian-vs-AfricanAmerican |
1.699550E-03 |
| Caucasian-vs-Asian |
3.801400E-01 |
| AfricanAmerican-vs-Asian |
1.911690E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.45529999998162E-07 |
| Normal-vs-Female |
1.162360E-02 |
| Male-vs-Female |
2.617700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.840010E-04 |
| Normal-vs-Age(41-60Yrs) |
1.646280E-04 |
| Normal-vs-Age(61-80Yrs) |
5.94529999999871E-05 |
| Normal-vs-Age(81-100Yrs) |
3.592400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.987370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.438200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.379600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.478000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.889600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.362400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.635600E-02 |
| Normal-vs-Grade 2 |
4.709700E-02 |
| Normal-vs-Grade 3 |
3.1007999999888E-06 |
| Normal-vs-Grade 4 |
3.09380299157169E-11 |
| Grade 1-vs-Grade 2 |
4.394800E-01 |
| Grade 1-vs-Grade 3 |
6.357600E-01 |
| Grade 1-vs-Grade 4 |
2.639800E-02 |
| Grade 2-vs-Grade 3 |
1.140460E-02 |
| Grade 2-vs-Grade 4 |
1.18330000020705E-07 |
| Grade 3-vs-Grade 4 |
1.024010E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.526400E-01 |
| Normal-vs-ccB subtype |
3.99160005049026E-09 |
| ccA subtype-vs-ccB subtype |
5.58089996438582E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.189100E-04 |
| Normal-vs-N1 |
3.623500E-04 |
| N0-vs-N1 |
2.291600E-01 |
|
|
